Evidence map›Paper›PMID 41404852›Full record

ArticleAlzheimer's & dementia : the journal of the Alzheimer's Association2025

Unraveling disparities in county-level dementia diagnosis prevalence across the United States.

Adam de Havenon, Lauren Littig, Guido J Falcone, Richa Sharma, Arman Fesharaki, Shadi Yaghi, Erick Calvario, Jonathan M Rosand, Kevin N Sheth, Christopher D Anderson

Abstract read
In one paragraph

Article in Alzheimer's & dementia : the journal of the Alzheimer's Association, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Adverse policing as a social exposome pathway: Implications for depression, cognition, and dementia risk.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2026
    Article
  2. Unraveling disparities in county-level dementia diagnosis prevalence across the United States.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Adam de HavenonDepartment of Neurology, Center for Brain and Mind Health, Yale University School of Medicine, New Haven, Connecticut, USA.ORCID 0000-0001-8178-8597
Lauren LittigDepartment of Neurology, Center for Brain and Mind Health, Yale University School of Medicine, New Haven, Connecticut, USA.ORCID 0009-0005-7389-0328
Guido J FalconeDepartment of Neurology, Center for Brain and Mind Health, Yale University School of Medicine, New Haven, Connecticut, USA.
Richa SharmaDepartment of Neurology, Center for Brain and Mind Health, Yale University School of Medicine, New Haven, Connecticut, USA.
Arman FesharakiDepartment of Neurology, Center for Brain and Mind Health, Yale University School of Medicine, New Haven, Connecticut, USA.
Shadi YaghiDepartment of Neurology, Brown University, Providence, Rhode Island, USA.
Erick CalvarioDepartment of Neurology, University of Utah, Salt Lake City, Utah, USA.
Jonathan M RosandDepartment of Neurology, Massachusetts General Hospital, Boston, Massachusetts, USA.
Kevin N ShethDepartment of Neurology, Center for Brain and Mind Health, Yale University School of Medicine, New Haven, Connecticut, USA.
Christopher D AndersonDepartment of Neurology, Massachusetts General Hospital, Boston, Massachusetts, USA.

Funding

Anticoagulation in ICH Survivors for Prevention and Recovery (ASPIRE)U01NS106513 · NINDS · YALE UNIVERSITY · PI Hooman Kamel, Kevin Navin Sheth · 2019 to 2026
$20.6M
Social networks and risk of delayed arrival to the hospital during strokeR01MD016178 · NIMHD · BRIGHAM AND WOMEN'S HOSPITAL · PI Amar Dhand, Kevin Navin Sheth · 2022 to 2026
$3.7M
The Recovery in Stroke Using PAP (RISE UP) StudyR01NR018335 · NINR · YALE UNIVERSITY · PI REDEKER, NANCY S, SHETH, KEVIN NAVIN · 2019 to 2023
$3.4M
Southern New England Partnership In Stroke Research, Innovation and Treatment (SPIRIT)U24NS107215 · NINDS · YALE UNIVERSITY · PI MARK Jay ALBERTS, Karen L Furie · 2018 to 2026
$3.0M
Blood Pressure Variability and Ischemic Stroke Outcome (BP-VISO)R01NS130189 · NINDS · YALE UNIVERSITY · PI Adam H. de Havenon · 2023 to 2026
$2.0M
CAPTIVA-MRIUG3NS130228 · NINDS · YALE UNIVERSITY · PI AMIN-HANJANI, SEPIDEH, CHATTERJEE, ARINDAM R. · 2023 to 2023
$1.9M
Yale Clinical Site: Investigations For Improved Neurological Treatments at Yale (INFINITY)U24NS107136 · NINDS · YALE UNIVERSITY · PI SHETH, KEVIN NAVIN, SPUDICH, SERENA S · 2018 to 2022
$1.7M
Measuring Brain Health Using Low-Field Portable MRIR21NS138995 · NINDS · YALE UNIVERSITY · PI DE HAVENON, ADAM H. · 2024 to 2024
$477k
Intensive Blood Pressure Reduction in Deep Intracerebral HemorrhageR03NS112859 · NINDS · YALE UNIVERSITY · PI FALCONE, GUIDO JOSE, SHETH, KEVIN NAVIN · 2019 to 2020
$84k
American Heart Association 17CSA33550004NIH)/NIH/NINDS R01EB301114NIH/NINDS R01MD016178NIH/NINDS R01NR018335NIH/NINDS R01NS11072NIH/NINDS R03NS112859NIH/NINDS U01NS106513NIH/NINDS U24NS107136NIH/NINDS U24NS107215NIMHD NIH HHS R01 MD016178(NINDS) R01NS130189(NINDS) R21NS138995(NINDS) UG3NS130228NINDS NIH HHS R01 NS130189NINDS NIH HHS R03 NS112859NINDS NIH HHS R21 NS138995NINDS NIH HHS U01 NS106513NINDS NIH HHS U24 NS107136NINDS NIH HHS U24 NS107215NINDS NIH HHS UG3 NS130228NINR NIH HHS R01 NR018335
6 · The paper itself

Abstract

introductionWe aimed to identify demographic, socioeconomic, and environmental factors contributing to county-level variation in dementia diagnosis prevalence across the United States.

methodsUsing 2020 Dementia Data Hub data covering 61.5 million Medicare beneficiaries, we modeled the top tertile of dementia diagnosis prevalence across 3076 counties. Forty-one county-level variables were evaluated using logistic regression and region-specific models.

resultsTop-tertile counties averaged 1986 dementia cases per 100,000 residents; 43.8% were in the South. The main model included seven predictors: higher diabetes prevalence, uninsured rate, fast-food access, White race prevalence, smaller household size, smoking rate, and elevation (area under the curve [AUC]: 0.84; 95% confidence interval: 0.82 to 0.85). Region-specific models improved accuracy (AUCs 0.83 to 0.89). DISCUSSION: Dementia diagnosis prevalence varies widely across the United States and can be predicted with high accuracy using a small set of regionally adaptable variables. Region-specific modeling may help policymakers identify high-burden communities, tailor prevention strategies, and monitor the impact of targeted interventions over time. HIGHLIGHTS: Six models tested predictors of county-level dementia diagnosis prevalence. Backward selection was the main model: seven variables, high accuracy (AUC = 0.84). Higher diabetes, uninsured rates, White race prevalence, and fast food linked to more dementia diagnoses. Larger households, higher elevation, and more smokers linked to less dementia diagnoses. Some predictors (e.g., elevation) likely act as proxies; collinearity limits causality.

Indexed as

DementiaAgedAged, 80 and overFemaleHumansMaleMedicarePrevalenceSocioeconomic FactorsUnited Statescounty‐level variationdementia diagnosis prevalenceneuroepidemiologypopulation healthpredictive modeling

Identifiers

PMID41404852
PMCPMC12709554

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.